| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2015 | Interwest Management Partners Ix, LLC | 10% Owner | Buy | 810,000 | $5.00 | $4,050,000.00 | +21.3% | |
| Apr 14, 2015 | Cha Albert | Director | Buy | 1,012,500 | $5.00 | $5,062,500.00 | +13.7% | |
| Apr 14, 2015 | Nohra Guy P | Director | Buy | 877,500 | $5.00 | $4,387,500.00 | +25.3% | |
| Apr 14, 2015 | Acmp IV LLC | 10% Owner | Buy | 877,500 | $5.00 | $4,387,500.00 | +25.3% |